Your browser doesn't support javascript.
loading
Author Correction: Breaking the performance ceiling for neoantigen immunogenicity prediction.
O'Brien, Hugh; Salm, Max; Morton, Laura T; Szukszto, Maciej; O'Farrell, Felix; Boulton, Charlotte; Becker, Pablo D; Samuels, Yardena; Swanton, Charles; Mansour, Marc R; Reker Hadrup, Sine; Quezada, Sergio A.
Afiliación
  • O'Brien H; Achilles Therapeutics Ltd, London, UK.
  • Salm M; Achilles Therapeutics Ltd, London, UK. m.salm@achillestx.com.
  • Morton LT; Achilles Therapeutics Ltd, London, UK.
  • Szukszto M; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
  • O'Farrell F; Achilles Therapeutics Ltd, London, UK.
  • Boulton C; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
  • Becker PD; Achilles Therapeutics Ltd, London, UK.
  • Samuels Y; Weizmann Institute of Science, Rehovot, Israel.
  • Swanton C; The Francis Crick Institute, London, UK.
  • Mansour MR; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
  • Reker Hadrup S; Technical University of Denmark, Lyngby, Denmark. sirha@dtu.dk.
  • Quezada SA; Achilles Therapeutics Ltd, London, UK. s.quezada@ucl.ac.uk.
Nat Cancer ; 5(4): 692, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38622449
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Cancer / Nat. cancer / Nature cancer Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Nat Cancer / Nat. cancer / Nature cancer Año: 2024 Tipo del documento: Article